UTMD

Utah Medical Products, Inc. · NASDAQ · Healthcare · USD · 10-K for 2025, filed 2026-03-27

Figures on this page computed 2026-11-08 12:40 UTC

Last close

72.42USD

Market data, 2026-11-04

Except where said otherwise: 10-K for 2025, filed 2026-03-27

20.8xP/E
Price / Earnings per Share (diluted)
Source
computed
Fiscal year
2025
Accession
0001096906-26-000395
Reported in
USD
- computed
- 10-K for 2025, filed 2026-03-27
The filing itself
26.8%ROIC
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
Source
computed
Fiscal year
2025
Accession
0001096906-26-000395
Reported in
USD
- 10-K for 2025, filed 2026-03-27
- 10-K for 2025, filed 2026-03-27
- 10-K for 2025, filed 2026-03-27
- 10-Q for 2025, filed 2026-08-12
- 10-K for 2025, filed 2026-03-27
- 10-Q for 2025, filed 2026-08-12
The filing itself
29.3%Net margin
Net Income / Revenue x 100
Source
computed
Fiscal year
2025
Accession
0001096906-26-000395
Reported in
USD
- 10-K for 2025, filed 2026-03-27
- 10-K for 2025, filed 2026-03-27
The filing itself
37.2%FCF margin
Free Cash Flow / Revenue x 100
Source
computed
Fiscal year
2025
Accession
0001096906-26-000395
Reported in
USD
- 10-K for 2025, filed 2026-03-27
- 10-K for 2025, filed 2026-03-27
The filing itself
0.004Debt/equity
Total Debt / Shareholders' Equity
Source
computed
Fiscal year
2025
Accession
0001096906-26-000395
Reported in
USD
- 10-K for 2025, filed 2026-03-27
- 10-Q for 2025, filed 2026-08-12
The filing itself
1.7%Dividend yield
Source
computed
Taken on
2026-11-07
Reported in
USD
- computed
- computed
- computed
- computed
- computed
- Computed from the filing for 2025, filed 2026-03-27

Growth is the furthest below its sector's middle: 0.28 against 0.47 on the market's range.

Follow one dollar

lens 1 of 9

After what it costs to make

57.1%

After running the business

29.6%

After interest and tax

29.3%

After what it must reinvest

37.2%

Kept after the dividend

26.8%

after what it costs to make, 57.1% of sales; after running the business, 29.6% of sales; after interest and tax, 29.3% of sales; after what it must reinvest, 37.2% of sales; kept after the dividend, 26.8% of sales

The five stops

5 of 5 read

After what it costs to make22,001,00057.1%
After running the business11,402,00029.6%
After interest and tax11,286,00029.3%
After what it must reinvest14,321,00037.2%
Kept after the dividend10,338,00026.8%

Of every unit of sales, 0.27 is still there after the dividend.

Every figure in this lens

Except where said otherwise: 10-K for 2025, filed 2026-03-27

Sales38,520,000
Source
filed
Statement
income
Fiscal year
2025
Accession
0001096906-26-000395
Reported in
USD
The filing itself
After what it costs to make22,001,000
Source
filed
Statement
income
Fiscal year
2025
Accession
0001096906-26-000395
Reported in
USD
The filing itself
After running the business11,402,000
Source
filed
Statement
income
Fiscal year
2025
Accession
0001096906-26-000395
Reported in
USD
The filing itself
After interest and tax11,286,000
Source
filed
Statement
income
Fiscal year
2025
Accession
0001096906-26-000395
Reported in
USD
The filing itself
After what it must reinvest14,321,000
Source
filed
Statement
income
Fiscal year
2025
Accession
0001096906-26-000395
Reported in
USD
The filing itself
Kept after the dividend10,338,000
Source
filed
Statement
income
Fiscal year
2025
Accession
0001096906-26-000395
Reported in
USD
The filing itself